SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Cleveland BioLabs Q1 EPS $(0.800) Down From $(0.110) YoY, Sales $156.000K Down From $227.576K YoY

Cleveland BioLabs (NASDAQ:CBLI) reported quarterly losses of $(0.800) per share. This is a 627.27 percent decrease over losses of $(0.110) per share from the same period last year. The company reported $156.000 thousand

Benzinga · 05/15/2020 13:06

Cleveland BioLabs (NASDAQ:CBLI) reported quarterly losses of $(0.800) per share. This is a 627.27 percent decrease over losses of $(0.110) per share from the same period last year. The company reported $156.000 thousand in sales this quarter. This is a 31.45 percent decrease over sales of $227.576 thousand the same period last year.